IOL Chemicals and Pharmaceuticals stock zooms nearly 6% on receiving patent right

25 Nov 2022 , 09:19 AM

IOL Chemicals & Pharmaceuticals Ltd has informed to the exchanges regarding granting of patent.

As per the regualtory filing, the Controller of Patent, Indian Patent Office; Government of India has granted Patent for invention entitled AN IMPROVED SAFE PROCESS FOR THE PREPARATION OF SARTAN DRUGS OF FORMULA I.

Further, Valsartan, Losartan, Irbesartan, Olmesartan, Candesartan and other Sartan drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.

On Friday, at around 9:18 AM, IOL Chemicals & Pharmaceuticals Ltd ended at Rs350.45 per share up by Rs19.7 or 5.96% from its previous closing of Rs330.75 per share on the BSE.

For feedback and suggestions, write to us at [e-mail]